AlphaGen
Access AlphaGen
Company Narratives

Ghani Global Glass Q3 FY26: Better Gross Margin Meets Export Shock and Higher Funding Costs

Ghani Global Glass improved Q3 gross margin despite weaker sales, but export disruption, finance costs and working-capital pressure drove a steep earnings decline.

Sep 22, 2026

Verdict

Ghani Global Glass Limited’s third quarter ended March 31, 2026 showed a sharp split between manufacturing margin and bottom-line earnings. Net sales fell 19.2% year on year to Rs657.2 million as local gross sales declined 11.0% and export gross sales collapsed 83.6%, yet gross profit was almost unchanged at Rs178.7 million. Quarterly gross margin therefore improved to 27.2% from 21.9%. The improvement did not survive below gross profit: administrative and selling expenses rose sharply, finance cost increased 26.9%, and profit after tax fell 75.0% to Rs19.7 million.

The nine-month picture was weaker. Net sales declined only 4.2% to Rs2.036 billion, but gross margin fell to 24.1% from 26.0%, operating profit dropped 30.9%, and profit after tax fell 71.0% to Rs70.7 million. Management attributes the deterioration to the Afghanistan-border closure, floods, higher raw-material prices and consumption, sharply lower other income, and start-up costs from a new glass furnace commissioned in July 2025. Q3 gross-margin recovery is encouraging, but it is not yet evidence of a full earnings recovery because export demand, operating overhead, funding costs and liquidity remain material constraints.

Results at a glance

  • Company: Ghani Global Glass Limited. Ticker: GGGL. Reporting period: quarter and nine months ended March 31, 2026. The condensed interim financial statements are unaudited; the June 30, 2025 statement-of-financial-position comparative is audited.
  • Q3 FY26 net sales were Rs657.2 million versus Rs813.7 million, down 19.2%. Gross profit was Rs178.7 million versus Rs177.9 million, while gross margin improved to 27.2% from 21.9%. Operating profit fell 15.4% to Rs126.8 million. Finance cost rose 26.9% to Rs89.0 million. Profit after tax fell to Rs19.7 million from Rs78.8 million, and EPS declined to Rs0.08 from Rs0.33.
  • 9MFY26 net sales were Rs2.036 billion versus Rs2.125 billion, down 4.2%. Gross profit fell 11.4% to Rs490.4 million and operating profit fell 30.9% to Rs373.1 million. Finance cost was almost flat at Rs266.9 million, but profit before levy and taxation fell 61.3% to Rs106.2 million and PAT fell 71.0% to Rs70.7 million. EPS was Rs0.30 versus Rs1.01.
  • Net operating cash flow improved to positive Rs199.1 million from a Rs52.9 million outflow. Even so, cash and bank balances fell to Rs55.6 million from Rs170.2 million at June 2025 because investing activities used Rs225.0 million and financing activities used Rs88.8 million.
  • AlphaGen model outputs — not company-reported figures: Alpha QoQ Score: 9.87; TTM Performance Score: 7.10; 3Y Business Perf Score: 57.98; Sector Leadership Score: 35.23.

The quarter was weaker on volume, but better on gross margin

The most unusual feature of Q3 is that a 19.2% revenue decline did not reduce gross profit. Cost of sales fell 24.7% to Rs478.5 million, faster than revenue, so quarterly gross margin expanded by roughly 5.3 percentage points. That is a meaningful positive signal after the pressure seen earlier in the fiscal year: the company generated more gross profit from each rupee of Q3 sales than it did a year earlier.

However, the filing does not explicitly attribute the standalone Q3 margin improvement to furnace stabilization, pricing, mix or a specific input-cost reversal, so assigning a single cause would be speculative. Management’s broader nine-month commentary is more cautious: the new furnace commissioned in July 2025 created elevated operating costs in its start-up phase, while higher raw-material prices and consumption also pressured profitability. The Q3 margin improvement may indicate some normalization, but that remains an inference rather than a management-stated conclusion.

Exports were the sharpest revenue pressure

The revenue weakness was concentrated in exports. Q3 gross export sales fell to Rs17.3 million from Rs105.7 million, an 83.6% decline, while local gross sales fell 11.0% to Rs745.6 million. Over nine months, export gross sales fell 60.8% to Rs52.5 million, whereas local gross sales declined only about 1.0%. This mix makes the external-market disruption economically significant even though exports are a relatively small share of total sales.

Management directly links the export decline to border closures amid Pakistan-Afghanistan tensions, saying the disruption affected pharmaceutical exports and reduced demand for the company’s glass tubes, ampoules and vials. That explanation is consistent with the government record: Pakistan’s Press Information Department reported in October 2025 that bilateral trade with Afghanistan had been temporarily halted because of security concerns, with export vehicles stranded at Torkham and other crossings. Management also says the 2025 floods constrained domestic demand; NDMA’s post-monsoon assessment confirms the severity and nationwide reach of the flood season.

The company additionally points to Middle East instability as an indirect constraint on pharmaceutical export demand. SBP’s March 9 monetary-policy statement separately noted that the regional conflict had pushed up fuel, freight and insurance costs and disrupted cross-border trade. That does not quantify the effect on GGGL, but it supports the broader operating backdrop described by management.

Why profit fell much faster than sales

The gap between a 4.2% nine-month sales decline and a 71.0% fall in PAT came from several layers. First, gross margin fell about 2.0 percentage points to 24.1%, so lower revenue generated disproportionately less gross profit. Second, administrative expense rose 37.1% to Rs97.7 million and selling and distribution expense rose 48.3% to Rs20.9 million. Third, other income collapsed to Rs9.9 million from Rs90.7 million, removing a large source of below-core support. The interim report does not fully decompose the comparable other-income balance, so it would be inappropriate to classify all of the prior-year amount as exceptional.

Finance cost remained heavy. For nine months it was Rs266.9 million, almost unchanged year on year and equal to about 72% of operating profit. In Q3 alone, finance cost rose 26.9% to Rs89.0 million while operating profit declined 15.4%. This explains why Q3 gross-margin improvement did not translate into stronger pretax earnings: profit before levy and taxation still fell 52.6% to Rs37.8 million.

Below that line, levy and final taxation was Rs49.4 million for nine months versus Rs20.2 million a year earlier, partly offset by an income-tax credit of Rs13.9 million. These tax-line movements matter to reported PAT, but operating profit remains the cleaner measure for judging the underlying manufacturing trajectory.

Cash flow improved, but working-capital quality needs scrutiny

The cash-flow statement is better than the income statement at first glance. Cash generated from operating activities before finance cost and tax reached Rs471.3 million, up from Rs344.4 million, and net operating cash flow turned positive at Rs199.1 million from a Rs52.9 million outflow. That is a real improvement in period cash generation.

Yet the working-capital detail shows why the quality of that improvement deserves attention. Inventory absorbed Rs414.2 million of cash during the nine months, stores and spares another Rs104.9 million, and trade payables fell by Rs137.6 million. Offsetting those drains, trade receivables released Rs163.2 million and the payable to a related party increased by Rs360.5 million. Positive operating cash flow was therefore achieved despite a large inventory build, with meaningful support from receivables collection and related-party working-capital funding.

The balance sheet shows the same tension. Stock in trade rose 56.4% from June to Rs1.149 billion and stores and spares rose to Rs448.5 million, while cash fell 67.4% to Rs55.6 million. Current assets of Rs3.283 billion still exceeded current liabilities of Rs3.107 billion, but only narrowly. Roughly half of current assets are tied up in inventory and stores rather than cash. The next result needs to show whether that inventory can be converted into sales and cash without sacrificing margin.

Conventional interest-bearing borrowings moved down modestly. Long-term financing fell to Rs324.6 million from Rs505.3 million, short-term borrowings edged down to Rs730.0 million from Rs751.1 million, while the current portion of long-term financing rose to Rs326.0 million from Rs203.8 million. Taken together, those principal borrowing lines were about Rs1.38 billion at March 2026 versus about Rs1.46 billion at June 2025.

The more important movement was the payable to a related party, which increased 26.1% to Rs1.743 billion and represented more than half of current liabilities. This is why a small decline in bank-style debt should not be read as broad deleveraging. Liquidity is increasingly dependent on the structure and availability of related-party funding while the company is simultaneously carrying elevated inventory and making capital expenditures.

Post-period, SBP raised its policy rate from 10.5% to 11.5%, effective April 28, 2026. Management itself flagged a recent one-percentage-point increase in financing rates as a potential drag on future profitability. With Q3 finance expense already rising materially, the next cycle should reveal whether lower principal borrowings can offset a higher rate environment.

New furnace and value-added capacity: strategic upside, execution risk

The new glass furnace is central to the operating story. Management says it was commissioned in July 2025 and that start-up inefficiencies increased operating costs during the first nine months. At the same time, the company reports that monthly production capacity for value-added products has increased to 55 million ampoules and 3 million vials. Management is implementing recommendations from a team of experts to improve furnace operations and the ampoule and vial manufacturing process, with the stated objective of reducing manufacturing cost and improving operating profit.

That creates a clear test for upcoming results. If furnace stabilization lowers unit costs while the company rebuilds export demand, the higher value-added capacity can improve earnings quality. If export channels remain constrained or the plant continues to consume more input per unit than expected, the enlarged production base can instead keep pressure on working capital, energy consumption and finance cost. The current filing provides capacity numbers and a process-improvement plan, but not utilization rates or quantified savings, so neither outcome should be assumed.

Sector context: pressure was real, but GGGL’s earnings fall was unusually severe

The glass sector did face genuine cost and demand pressure, but peer evidence shows it was not uniform. Ghani Glass Limited reported nine-month revenue up about 4.7% and PAT up about 7.0%. Tariq Glass Industries, by contrast, reported nine-month sales down about 8.3% and PAT down about 16.0%, citing subdued demand, competition, elevated energy tariffs and higher input costs. These businesses are not perfect like-for-like peers, but together they show a mixed sector rather than a universal collapse.

Against that backdrop, GGGL’s 4.2% revenue decline is not extraordinary, but the 71.0% fall in PAT is. The company-specific explanation is visible in its own filing: furnace start-up costs, the sharp export drop, the disappearance of most prior-year other-income support, higher operating expenses and a finance-cost burden that absorbed much of operating profit. The next earnings cycle should therefore be judged less by top-line growth alone and more by margin normalization, export recovery and cash conversion.

What improved

  • Q3 gross profit held broadly flat despite a 19.2% sales decline, lifting gross margin to 27.2% from 21.9%.
  • Net operating cash flow improved to Rs199.1 million from a Rs52.9 million outflow.
  • Trade receivables fell 18.0% from June to Rs741.3 million, releasing working capital.
  • Principal interest-bearing borrowing lines were modestly lower than at June 2025.
  • Management reports materially higher capacity in value-added ampoules and vials, although utilization and economics still need to be proven.

What weakened / needs attention

  • Q3 net sales fell 19.2%, with gross export sales down 83.6%.
  • Q3 finance cost rose 26.9% while operating profit fell 15.4%, compressing pretax profit.
  • 9MFY26 operating profit fell 30.9% and PAT fell 71.0%.
  • Other income fell almost 90% over nine months, removing a significant source of prior-year earnings support.
  • Inventory and stores expanded sharply while cash fell to Rs55.6 million.
  • Related-party payables rose to Rs1.743 billion, increasing dependence on group funding.
  • Post-period interest rates moved higher, adding another variable to an already large finance-cost burden.

Recurring versus non-recurring earnings drivers

  • Core recurring drivers: domestic and export sales volumes, product mix, furnace efficiency, raw-material and energy costs, administrative and distribution costs, and finance cost. These will determine whether the Q3 gross-margin improvement can become a sustained operating recovery.
  • Transition-related but potentially temporary: start-up inefficiencies from the furnace commissioned in July 2025. Management expects process improvements, but the filing does not quantify the timing or savings.
  • Non-core and variable support: other income. It fell to Rs9.9 million from Rs90.7 million over nine months. Because the current interim filing does not fully decompose the prior-year balance, readers should not assume either the old or current level will recur.
  • Tax and levy effects materially affected reported PAT, but they are not substitutes for analysis of operating profitability.

What to monitor next

  • Q4/FY26 export sales, especially whether the Afghanistan channel normalizes and whether Middle East demand improves.
  • Gross margin after the furnace has had additional time to stabilize; Q3’s 27.2% margin is the key benchmark.
  • Inventory conversion: whether the Rs1.149 billion stock balance turns into revenue and cash without discounting or a further working-capital build.
  • Related-party funding: whether the Rs1.743 billion payable continues to rise, is converted or repaid, and what financing cost it carries.
  • Finance cost after SBP’s post-period rate increase and whether lower principal borrowings provide enough offset.
  • Utilization of the expanded ampoule and vial capacity and evidence that process-improvement recommendations are reducing unit manufacturing cost.
  • Operating cash flow without further support from working-capital liability growth.

Bottom line

Ghani Global Glass’ Q3 FY26 result contains an encouraging manufacturing signal but a weak earnings outcome. The company produced almost the same gross profit on materially lower sales and lifted quarterly gross margin by more than five percentage points. Yet export revenue fell sharply, overhead and finance costs rose, and quarterly PAT dropped by three quarters. Over nine months, furnace start-up costs, higher inputs and the loss of prior-year other-income support produced a much deeper profit decline than the modest revenue contraction would suggest.

The next result cycle is therefore about conversion. GGGL needs to convert its better Q3 gross margin and expanded value-added capacity into sustained operating profit, while reducing inventory intensity and dependence on related-party funding. Export recovery would help, but the stronger proof of improvement will be whether furnace efficiency, working-capital discipline and financing costs allow cash and bottom-line earnings to recover together.

Sources

Explore more research

All articles